Several of the genes that we identified are particularly prominent in cancer types in which they are known to be highly mutated, such as VHL in renal cancer, PIK3CA in breast cancer, TP53 in ovarian cancer, SMAD4 in esophageal and gastric cancer, and KRAS in pancreatic cancer. This evidence concerns the gene SMAD4 and ovarian carcinoma.